Topical Quercetin and Resveratrol Protect the Ocular Surface in Experimental Dry Eye Disease

References

• Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264–1268.
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318–326.
   PubMed Web of Science ®Google Scholar
• Bron AJ, De Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438–510.
   PubMed Web of Science ®Google Scholar
• Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012;31:271–285.
   PubMed Web of Science ®Google Scholar
• Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. Int Rev Immunol. 2013;32:19–41.
   PubMed Web of Science ®Google Scholar
• Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AKPS. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584–589.
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC. Solomon a, Stern ME. The diagnosis and management of dry eye: a twenty-five-year review. Cornea. 2000;19:644–649.
   PubMed Web of Science ®Google Scholar
• Enríquez-de-Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862–873.
   PubMed Web of Science ®Google Scholar
• Reinoso R, Calonge M, Castellanos E, et al. Differential cell proliferation, apoptosis, and immune response in healthy and evaporative-type dry eye conjunctival epithelia. Investig Ophthalmol Vis Sci. 2011;52(7):4819–4828.
   PubMed Web of Science ®Google Scholar
• Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol. 2000;118:1489–1496.
   PubMed Web of Science ®Google Scholar
• Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: A clinical and immunocytochemical study. Am J Ophthalmol. 2003;136:593–602.
   PubMed Web of Science ®Google Scholar
• Pinto-Fraga J, Lopez-Miguel A, Gonzalez-Garcia MJ, et al. Topical fluorometholone protects the ocular surface of dry eye patients from desiccating stress: A randomized controlled clinical trial. Ophthalmology. 2016;123(1):141–153.
   PubMed Web of Science ®Google Scholar
• Garrott HM, Walland MJ. Clinical case notes. Glaucoma from topical corticosteroids to the eyelids. Clin Exp Ophthalmol. 2004;32:224–226.
   PubMed Web of Science ®Google Scholar
• Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology. 2000;47:119–125.
   PubMed Web of Science ®Google Scholar
• Colgan J, Asmal M, Yu B, Luban J. Cyclophilin A-deficient mice are resistant to immunosuppression by cyclosporine. J Immunol. 2005;174:6030–6038.
   PubMed Web of Science ®Google Scholar
• Perez VL, Pflugfelder SC, Zhang S, Shojaei A, Haque R. Lifitegrast, a novel integrin antagonist for treatment of dry eye disease. Ocul Surf. 2016;14:207–215.
   PubMed Web of Science ®Google Scholar
• González R, Ballester I, López-Posadas R, et al. Effects of flavonoids and other polyphenols on inflammation. Crit Rev Food Sci Nutr. 2011;51(4):331–362.
   PubMed Web of Science ®Google Scholar
• Davis JM, Murphy EA, Carmichael MD. Effects of the dietary flavonoid quercetin upon performance and health. Curr Sports Med Rep. 2009;8:206–213.
   PubMed Web of Science ®Google Scholar
• Hou D-X, Kumamoto T. Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling. Antioxid Redox Signal. 2010;13:691–719.
   PubMed Web of Science ®Google Scholar
• Vicentini FT, He T, Shao Y, et al. Quercetin inhibits UV irradiation-induced inflammatory cytokine production in primary human keratinocytes by suppressing NF-kappaB pathway. J DermatolSci. 2011;61(3):162–168.
   Google Scholar
• Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res. 2009;2:409–418.
   PubMed Web of Science ®Google Scholar
• Sharma S, Chopra K, Kulkarni SK, Agrewala JN. Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clin Exp Immunol. 2007;147:155–163.
   PubMed Web of Science ®Google Scholar
• De La Lastra CA, Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res. 2005;49:405–430.
   PubMed Web of Science ®Google Scholar
• Kelly GS. Quercetin. Monograph. Altern Med Rev a J Clin Ther. 2011;16:172–194.
   PubMedGoogle Scholar
• Abengózar-Vela A, Calonge M, Stern ME, González-García MJ, Enríquez-De-Salamanca A. Quercetin and resveratrol decrease the inflammatory and oxidative responses in human ocular surface epithelial cells. Invest Ophthalmol Vis Sci. 2015;56:2709–2719.
   PubMed Web of Science ®Google Scholar
• Dursun D, Wang M, Monroy D, et al. A mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci. 2002;43(3):632–638.
   PubMed Web of Science ®Google Scholar
• Niederkorn JY, Stern ME, Pflugfelder SC, et al. Desiccating stress induces T cell-mediated Sjögren’s Syndrome-like lacrimal keratoconjunctivitis. J Immunol. 2006;176(7):3950–3957.
   PubMed Web of Science ®Google Scholar
• Cavet ME, Harrington KL, Vollmer TR, Ward KW, Zhang J-Z. Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells. Mol Vis. 2011;17:533–542.
   PubMed Web of Science ®Google Scholar
• Lee HS, Chauhan SK, Okanobo A, Nallasamy N, Dana R. Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye. Cornea. 2011;30:1465–1472.
   PubMed Web of Science ®Google Scholar
• Lemp MA. Report of the National eye institute/Industry workshop on clinical trials in dry eyes. CLAO J. 1995;21:221–232.
   PubMedGoogle Scholar
• Siemasko KF, Gao J, Calder VL, et al. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Investig Ophthalmol Vis Sci. 2008;49(12):5434–5440.
   PubMed Web of Science ®Google Scholar
• Schaumburg CS, Siemasko KF, De Paiva CS, et al. Ocular surface APCs are necessary for autoreactive T cell-mediated experimental autoimmune lacrimal keratoconjunctivitis. J Immunol. 2011;187(7):3653–3662.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chauhan SK, Lee HS, et al. Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis. Invest Ophthalmol Vis Sci. 2013;54(4):2457–2464.
   PubMed Web of Science ®Google Scholar
• Corrales RM, Villarreal A, Farley W, Stern ME, Li D-Q, Pflugfelder SC. Strain-related cytokine profiles on the murine ocular surface in response to desiccating stress. Cornea. 2007;26:579–584.
   PubMed Web of Science ®Google Scholar
• Boehm N, Riechardt AI, Wiegand M, Pfeiffer N, Grus FH. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Investig Ophthalmol Vis Sci. 2011;52:7725–7730.
   PubMed Web of Science ®Google Scholar
• Na KS, Mok JW, Kim JY, Rho CR, Joo CK. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Investig Ophthalmol Vis Sci. 2012;53:5443–5450.
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren’s syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19:201–211.
   PubMed Web of Science ®Google Scholar
• Lam H, Bleiden L, De Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009: 147(2): 198–205. e1
   PubMed Web of Science ®Google Scholar
• Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283–2292.
   PubMed Web of Science ®Google Scholar
• Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci. 1999;40:2506–2512.
   PubMed Web of Science ®Google Scholar
• Oh HN, Kim CE, Lee JH, Yang JW. Effects of Quercetin in a mouse model of experimental dry eye. Cornea. 2015;34:1130–1136.
   PubMed Web of Science ®Google Scholar
• Pitcher JD, De Paiva CS, Pelegrino FSA, et al. Pharmacological cholinergic blockade stimulates inflammatory cytokine production and lymphocytic infiltration in the mouse lacrimal gland. Investig Ophthalmol Vis Sci. 2011;52(6):3221–3227.
   PubMed Web of Science ®Google Scholar
• Saito K, Mori S, Date F, Hong G. Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB. Autoimmunity. 2015;48:379–388.
   PubMed Web of Science ®Google Scholar
• Takahashi A, Inoue H, Mishima K, et al. Evaluation of the effects of quercetin on damaged salivary secretion. PLoS One. 2015;10(1):e0116008.
   PubMed Web of Science ®Google Scholar
• Gupta R, Gupta LK, Mediratta PK, Bhattacharya SK. Effect of resveratrol on scopolamine-induced cognitive impairment in mice. Pharmacol Reports. 2012;64:438–444.
   PubMed Web of Science ®Google Scholar
• Palle S, Neerati P. Quercetin nanoparticles attenuates scopolamine induced spatial memory deficits and pathological damages in rats. Bull Fac Pharmacy Cairo Univ. 2016;55:101–106.
   Google Scholar
• Guzmán M, Keitelman I, Sabbione F, Trevani AS, Giordano MN, Galletti JG. Desiccating stress-induced disruption of ocular surface immune tolerance drives dry eye disease. Clin Exp Immunol. 2016;184:248–256.
   PubMed Web of Science ®Google Scholar
• Zheng X, De Paiva CS, Li DQ, Farley WJ, Pflugfelder SC. Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway. Investig Ophthalmol Vis Sci. 2010;51:3083–3091.
   PubMed Web of Science ®Google Scholar
• Pinto-Fraga J, Enríquez-de-Salamanca A, Calonge M, et al. Severity, therapeutic, and activity tear biomarkers in dry eye disease: an analysis from a phase III clinical trial. Ocul Surf. May 2018. doi:10.1016/j.jtos.2018.05.001. [ Epub ahead of print].
   Web of Science ®Google Scholar